Locations:
Search IconSearch
June 18, 2019/Neurosciences

Identifying Risks Factors Associated With Extended Length of Stay in Posterior Segmental Instrumented Fusion for Adolescent Idiopathic Scoliosis

Effective pain relief and major postoperative complications correlate with length of stay, study finds

16-ort-2676-goodwin-hero-image-650x450pxl

The use of epidural analgesia (EA) may be a protective factor against extended length of stay (LLOS) in patients undergoing posterior segmental instrumented fusion (PSIF) for adolescent idiopathic scoliosis (AIS).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A retrospective cohort study, recently published in the journal Spine Deformity, analyzed a variety of demographic and surgical factors in order to identify independent risk factors associated with increased LOS. The two factors most strongly associated with LLOS were major postoperative complications and the use of EAs for pain management. Other factors with statistically significant correlations were female sex, ≥9 ±2 levels of fusion, amount of operative blood loss, major postoperative complications, lack of EA and higher thoracic kyphosis.

“Length of stay is important in an era of value-based care; however, studies such as this one are concerned with more than reimbursement,” states Ryan Goodwin, MD, Director of Cleveland Clinic’s Center for Pediatric and Adolescent Orthopaedics. “The modifiable risk factors we identified, such as effective pain relief and major postoperative complications, relate to patient safety and well-being and overall quality of care.”

Identifying risks factors associated with extended length of stay

The study involved retrospective analysis of data from pediatric scoliosis patients (n = 407) undergoing surgical correction from January 1, 2009 through December 31, 2017. Researchers defined a short length of stay (SLOS) as fewer than four days, and a LLOS as four or more days.

Of the patients included in this single-institution study, 232 had SLOS, with a mean stay of 3 ±0.5 days. The remaining 175 patients had LLOS, with a mean stay of 6 ±2 days. Researchers looked at factors related to a patient’s demographics, comorbidities and preoperative measurements of scoliosis curve, as well as factors related to the surgery itself and any complications.

Advertisement

Among the demographic characteristics, only female sex had statistically significant associations with LLOS. Higher thoracic kyphosis was the only preoperative radiographic measurement to correlate with LLOS. Comorbidities had no statistically significant impact on LOS.

In terms of surgery-related characteristics and postoperative complications, which might be considered somewhat modifiable risk factors, operative time and the number of osteotomies had no significant impact on LOS. Patients in whom 7 ±2 levels were fused had SLOS compared to patients who had 9 ±2 levels fused.

Opportunity to make meaningful improvements in quality of care

In patients with major postoperative complications, such as the development of motor weakness, the need for transfusion, infection or reoperation, the risk of LLOS increased 11-fold. Patients without EA for pain control, a modifiable factor, had a three-fold increased risk of LLOS. Comorbidities, preoperative curve Cobb angle and number of osteotomies did not have a statistically significant impact on LOS.

Dr. Goodwin notes, “To our knowledge, this is the largest single-institution study, looking at the most comprehensive list of potential risk factors that might impact length of stay in this patient population. One day in a U.S. hospital can cost up to $4,000. Lowering these costs by reducing the number of in-hospital recovery days is good for everyone involved—patients, providers and payers.”

Advertisement

Related Articles

Dr. Alexandra Bonner against a decorative background with podcast overlay
June 2, 2025/Neurosciences/Podcast
Spinal Muscular Atrophy: Progress Continues Against a Grave Neuromuscular Disorder (Podcast)

As genetic insights refine diagnosis, research abounds on current and emerging therapies

four colored brain scans against black background
May 28, 2025/Neurosciences/Epilepsy
Clinical Application of MR Fingerprinting in Epilepsy Advances With NIH Grant Renewal

Researchers pair quantitative imaging with AI to improve surgical outcomes in nonlesional epilepsy

person walking with a stick-figure overlay on his body
A Peek Inside a Transformative Care Space in Our New Neurological Building

Novel ‘assessment center’ will be a partner in care by serving as an engine of structured data collection

rendering of a two-tower medical building
How Our New Neurological Building Will Democratize Care Access Through Distance Health

Advanced connectivity and technologies build on a foundation of teleneurology leadership

Image of Dr. Tara DeSilva with associate looking at computer
New WAM Grants Support Research on Blood-Brain Barrier, Microbial Metabolites and Microglia

Alzheimer’s studies delve into sex-related variances in the expression of the disease

Dr. Nina Moore against a decorative background with a podcast button overlay
May 16, 2025/Neurosciences/Podcast
New Insights Shaping Procedural Decision-Making in Cerebrovascular Disorders (Podcast)

Evolving thinking on when and how to treat brain aneurysms and AVMs

scan of a fractured human skull
What’s New in Neurotrauma Care? Two Trends for Neurosurgeons to Note

New guidance on penetrating head injuries, and noninvasive diagnostics get a nod in austere settings

Portrait of Dr. Oguh
Ataxia: A Symptom That Points to the Need for a Deeper Dive (Podcast)

Multidisciplinary care can be key to managing challenging condition

Ad